Correlation of King’s Sarcoidosis Questionnaire with clinical parameters

B. Frye (Freiburg, Germany), E. Farin-Glattacker (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America)

Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Session: Clinical issues in granulomatous lung diseases
Session type: E-poster session
Number: 3016

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Frye (Freiburg, Germany), E. Farin-Glattacker (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America). Correlation of King’s Sarcoidosis Questionnaire with clinical parameters. 3016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Translation and initial validation of King’s Sarcoidosis Questionnaire
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Health Related Quality of Life (HRQL) in sarcoidosis – Sarcoidosis Health Questionnaire (SHQ) and correlation with clinical course of sarcoidosis – follow up study
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006

A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
Source: Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Year: 2019

Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis
Source: Eur Respir J 2012; 39: 899-905
Year: 2012

Prevalence of Anxiety Disorders and Depression in Patients with Chronic Obstructive Pulmonary Disease and correlation with the clinical stage of the disease
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021

Assessing sarcoidosis: The King‘s Sarcoidosis Questionnaire and the minimal important difference
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012

Validity and reliability of the Stanford Brief Activity Survey (SBAS) in patients with COPD
Source: Annual Congress 2010 - Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise
Year: 2010

King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

The Profile of Sarcoidosis in Greece: Clinical characteristics, Extra-pulmonary manifestations, Long-term Follow-up
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020

The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Psychometric validation of the Korean PROMIS-29 Profile v2.1 among patients with chronic pulmonary diseases in Korea
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021

Translation and validation of the Quality-of-Life Bronchiectasis questionnaire in Swedish, and correlation with clinical outcomes.
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021

Comparative Evaluation of Clinical, Spiro/Oscillometric and Tomographic Parameters As A Global Assessment of Children With Cystic Fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Reliability & validity testing of the Seattle Pulmonary Exacerbation score in paediatric patients with CF
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) validated to Portuguese respiratory patients
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019

Development of pediatric cross-cultural patient-reported outcome measures: QOL-PCD
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014

Health-related quality of life in COPD: why both disease-specific and generic measures should be used
Source: Eur Respir J 2001; 18: 69-76
Year: 2001

Clinical and laboratory parameters to categorise Sarcoidosis
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004